Feeds:
Posts
Comments

Archive for June, 2011

By now, most pharma/biotech/med device companies have concluded that social media is important, is here to stay – and somehow needs to be included in future communications.

Most large companies have at least begun the process of hashing out the use of social media – how to use the various platforms, governance, internal ownership, content approval, SOP development, risk mitigation strategies, etc., etc.

If your company is looking to be in this (unavoidable) race, how do you get to the starting line?

In the early years of pharma social media (I’m only talking about 3-4 circuits around the sun, now!), typically one or two advocates emerged within a company and began the long process of evangelizing, with a lot of process development and pilot projects happening on the fly. Others leaned on digital agencies to help jump-start the process (or as an outsource partner).

Organic internal initiative, or high-priced agency intervention, each can have their place. But….

Here’s another idea – consider hiring on a Social Media Sherpa.

Sherpas, in mountaineering terms, are local guides to help people climb imposing mountains such as the Himalayas. Sherpas know the landscape, provide guidance, and can do a lot of the heavy lifting.

A Social Media Sherpa can be engaged for 3-9 months to help you get to the starting line. A sherpa knows the platforms, the tools, the regulatory environment – he or she already has experience in digital networks and can serve as the initial guide and trainer to safely move the company forward into the world of social networks.

Getting started involves a lot of collaboration and process development, and to be successful you want an experienced guide who has walked these paths beforehand. This may be one of the most valuable consulting retainers you ever invest in.

Realistically, I can work with only one client at a time doing a sherpa engagement, but there are others who have the corporate/social media experience and makeup to do this really well. If your company would benefit from this approach, let me know. I can make the right connections for you.

(Image credit)

———-

Sign up for the Impactiviti Connection weekly e-newsletter (see sample), chock full of news and resources for pharmaceutical professionals

Get the Impactiviti overview

Read Full Post »

Keep Your Limbs to Yourself!

Every day, 225 diabetics will undergo a lower limb amputation. That’s the equivalent of a 747 full of passengers crashing every day. Of those 225, 30% will require a second amputation within three years and 50% of those 225 will die within five years of that first amputation.

Yet, it seems like no one is blogging about this silent killer — Diabetic Peripheral Neuropathy (DPN).  Of all diabetes complications, foot disease is the leading cause of hospitalization.

Join the folks from Pam Labs (disclosure: client of a friend) on Tuesday June 28th at 8pm ET in an exclusive, invite only 20-minute webinar where DPN will be discussed:
    DPN: Exactly how big is the problem? The stats, the facts, and a few key infographics
    Challenges and Unmet Needs of DPN sufferers
    Signs / Symptoms and Clinical Impact
    Current Therapeutic Strategies
    Introduction to an Emerging Therapeutic Approach
You can register to attend via this link http://budurl.com/DPNWeb.
———-

Sign up for the Impactiviti Connection weekly e-newsletter (see sample), chock full of news and resources for pharmaceutical professionals

Get the Impactiviti overview

Read Full Post »

Ummmm….maybe not. At least, that’s the stance of the FDA, and of pretty much anyone with common sense. But – not all pharma sales reps have common sense.

A self-produced YouTube video to detail a product in an unfair and unbalanced manner? Sheesh!

Note to pharma clients: worth including this as a case study in your compliance training for sales reps.

(hat tip for link: Larry Lynam)

———-

Sign up for the Impactiviti Connection weekly e-newsletter (see sample), chock full of news and resources for pharmaceutical professionals

Get the Impactiviti overview

Read Full Post »